Diabetes

This research service aims to provide an update on the epidemiology of T2 diabetes, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in South Korea.

Currently in Mexico there are more than 10 million diabetics, from which only 20% is under correct control. Population growth and aging are some of the factors that keep increasing the potential for this market. Consequently increasingly more brands and products have been introduced into this market, splitting the diabetes therapy business in three...

Research was carried out on the Diabetes Market in the Kenyan Healthcare Industry. A thorough PESTLE (political, economic, social, technology, legislation, and environmental) analysis was established for Kenya. Market sizes for both the insulin and oral anti-diabetic drugs sectors were calculated for 2006 and forecasts were determined for the per...

Research was carried out on the Diabetes Market in the South African Healthcare Industry. A thorough PESTLE (political, economic, social, technology, legislation, and environmental) analysis was established for South Africa. Market sizes for both the insulin and oral anti-diabetic drugs sectors were calculated for 2006 and forecasts were determin...

This research service outlines the key developments taking place globally and emerging trends in the field of noninvasive technologies for glucose monitoring.

This research service analyzes the market for diabetes in vitro diagnostics within the United States. This service covers market trends, technology trends, competitive structure, revenue forecasts, market drivers and restraints. The key challenges and strategies are also covered.

The diabetes diagnostics market in South Korea is classified into two market segments as laboratory diabetes diagnostics segment and POCT diabetes diagnostics segment. The analysis time frame for this study was from 2002 to 2012, with 2005 being the base year of the study. The forecast period is 2006 to 2012 and historic period is 2002 to 2004.

The diabetes diagnostics market in Japan is classified into two market segments as laboratory diabetes diagnostics segment and POCT diabetes diagnostics segment. The analysis time frame for this study was from 2002 to 2012(CAGR period), with 2005 being the base year of the study. The forecast period is 2006 to 2012 and historic period is 2002 to 20...

This research service covers the pharmaceutical industry development pipeline for diabetes mellitus in the United States, with 2005 as the base year. Included are both the products projected to enter the market by the end of the forecast coverage period in 2012, as well as products entering the market in 2005 that correspond to the in-depth discuss...